Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCA-894A in Charcot-Marie-Tooth Disease Type 2S
NCT07223632Phase 2Active, not recruiting
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- May 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 2 trial of VCA-894A in Charcot-Marie-Tooth disease type 2S (CMT2S), sponsored by Vanda Pharmaceuticals Inc.. Started May 2025; status: active, not recruiting.
02
Drugs
VCA-894A
03
Conditions
Charcot-Marie-Tooth disease type 2S (CMT2S)
Beyond the preview
Go deeper on NCT07223632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07223632.